Autopsy report · NCT00967512

Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

“Study Was Terminated due to lack of Funding.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Eleos, Inc.

Sponsor type

Industry

Conditions

Acute Myelogenous Leukemia

Interventions

cenersen; placebo; idarubicin, cytarabine

Participants

0

Trials that died the same way

• 3D X-ray Motion Analysis of Ankle-foot Motion After Total Ankle Arthroplasty
  “Study was terminated due to lack of funding and unforeseen delays.” (96% match in meaning)
• Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX
  “Study terminated due to inadequate funding.” (95% match in meaning)
• A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
  “Study Terminated due to lack of Funding” (94% match in meaning)
• Therapeutic Exercise in Patients With Hemophilia
  “The Study was terminated due to lack of funding for continuing” (94% match in meaning)
• PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA
  “We terminated the study due to lack of funding” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.